Oral Abstract: MM-119: Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM).

Autor: Usmani, Saad Z., Berdeja, Jesus G., Madduri, Deepu, Jakubowiak, Andrzej, Agha, Mounzer, Cohen, Adam D., Hari, Parameswaran, Yeh, Tzu-Min, Olyslager, Yunsi, Banerjee, Arnob, Jackson, Carolyn C, Allred, Alicia, Zudaire, Enrique, Deraedt, William, Wu, Xiaoling, Carrasco-Alfonso, Marlene J., Akram, Muhammad, Yi Lin, Martin, Thomas, Jagannath, Sundar
Zdroj: Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS202-S202, 1p
Databáze: Complementary Index
Externí odkaz: